G Petur Nielsen Selected Research

G Petur Nielsen Research Topics

Disease

60	Neoplasms (Cancer) 04/2022 - 03/2003
15	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 04/2007
12	Chordoma 01/2021 - 09/2009
9	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 07/2009
9	Neoplasm Metastasis (Metastasis) 11/2020 - 10/2007
5	Necrosis 01/2022 - 03/2003
5	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 01/2005
4	Chondrosarcoma 01/2021 - 03/2003
4	Margins of Excision 01/2019 - 07/2010
3	Bone Cysts (Bone Cyst) 04/2022 - 01/2018
3	Giant Cell Tumors (Giant Cell Tumor) 04/2022 - 01/2016
3	Carcinoma (Carcinomatosis) 05/2021 - 01/2007
3	Giant Cell Tumor of Bone 01/2021 - 01/2016
3	Liposarcoma 01/2020 - 01/2014
3	Lipoma (Lipomata) 01/2020 - 01/2013
2	Bone Neoplasms (Bone Cancer) 04/2022 - 01/2019
2	Neurofibrosarcoma (MPNST) 10/2019 - 07/2009
2	Tuberous Sclerosis (Bourneville's Disease) 06/2019 - 01/2018
2	Fibroma (Fibromatosis) 06/2019 - 01/2018
2	Perivascular Epithelioid Cell Neoplasms 06/2019 - 01/2018
2	Fibrosis (Cirrhosis) 01/2019 - 08/2012
2	Pain (Aches) 07/2016 - 11/2015
2	Essential Osteolysis 11/2015 - 12/2006
2	Papillary Carcinoma 08/2015 - 01/2007
2	Synovial Sarcoma (Synovioma) 12/2014 - 01/2011
1	Osteoblastoma 04/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Aneurysmal Bone Cysts 04/2022
1	Histiocytic Sarcoma 01/2021
1	Disease Progression 01/2021
1	Mesothelioma 11/2020
1	Genetic Translocation (Chromosomal Translocation) 11/2020
1	Angiomatoid Fibrous Histiocytoma 11/2020
1	Spontaneous Fractures (Pathological Fracture) 09/2019
1	Calcinosis 05/2018
1	Chondroblastoma 01/2018

Drug/Important Bio-Agent (IBA)

8	RNA (Ribonucleic Acid)IBA 12/2021 - 07/2014
8	Keratins (Keratin)IBA 11/2020 - 01/2005
7	DesminIBA 12/2019 - 04/2003
6	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2009
5	Biological ProductsIBA 11/2020 - 04/2002
5	S100 Proteins (S 100 Protein)IBA 12/2019 - 04/2003
5	Protons (Proton)IBA 01/2017 - 07/2009
4	Denosumab FDA Link 04/2022 - 01/2016
4	Brachyury protein (Brachyury)IBA 01/2020 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2019 - 02/2010
3	Pharmaceutical PreparationsIBA 07/2014 - 11/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 03/2003
3	VimentinIBA 07/2013 - 04/2003
2	Monoclonal AntibodiesIBA 01/2021 - 01/2018
2	Histocompatibility Antigens Class IIBA 01/2021 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 05/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 05/2009
2	ParaffinIBA 01/2021 - 01/2007
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 11/2014
2	MyogeninIBA 10/2019 - 01/2019
2	Histones (Histone)IBA 10/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 09/2019 - 07/2014
2	MicroRNAs (MicroRNA)IBA 09/2019 - 06/2010
2	trans-sodium crocetinate (crocetin)IBA 06/2019 - 01/2018
2	LigandsIBA 01/2016 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 06/2010
2	Indicators and Reagents (Reagents)IBA 01/2013 - 06/2010
2	TrabectedinIBA 06/2010 - 03/2003
2	CollagenIBA 06/2010 - 07/2003
1	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2021
1	AntigensIBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	BuffersIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Xylenes (Xylene)IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	VaccinesIBA 01/2021
1	Keratin-1IBA 12/2019
1	NucleotidesIBA 11/2019
1	Lysine (L-Lysine)FDA Link 10/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	ChromatinIBA 01/2019
1	CalciumIBA 05/2018
1	Tyrosine Kinase InhibitorsIBA 10/2017
1	green 5IBA 10/2017

Therapy/Procedure

17	Therapeutics 01/2022 - 03/2003
15	Radiotherapy 01/2019 - 04/2007
9	Drug Therapy (Chemotherapy) 01/2022 - 03/2003
4	Neoadjuvant Therapy 01/2019 - 11/2011
3	Curettage 01/2022 - 02/2009
2	Adjuvant Radiotherapy 01/2019 - 08/2014
2	Proton Therapy 01/2017 - 06/2010
2	Aftercare (After-Treatment) 09/2009 - 07/2009
1	Negative-Pressure Wound Therapy 04/2022
1	Immunotherapy 01/2021